TECX
TECX
NASDAQ · Biotechnology

Tectonic Therapeutic Inc

$29.88
-0.95 (-3.08%)
As of Mar 22, 10:23 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +24.6% upside
Low Target $31.47
Average Target $37.23
High Target $57.92
Current Price $29.88
Current
$29.88
Target
$37.23
$31.47 $37.23 avg $57.92
Scenario Analysis
Bear Case
$31.47
5.3%
Low target
Base Case
$37.23
+24.6%
Avg target
Bull Case
$57.92
+93.8%
High target
Risk/Reward
17.6x
Highly favorable
Price in Context
52-Week High
$31.88
-6.3% from high
52-Week Low
$13.70
+118.1% from low
Target vs 52W High
$37.23
+16.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%